New sars-cov-2 variants challenge vaccines protection

dc.contributor.author	Soriano, Vicente
dc.contributor.author	Fernandez-Montero, José V.
dc.date	2021
dc.date.accessioned	2021-06-16T09:01:41Z
dc.date.available	2021-06-16T09:01:41Z
dc.identifier.issn	1139-6121
dc.identifier.uri	https://reunir.unir.net/handle/123456789/11486
dc.description.abstract	By the end of February 2021, roughly 115 million people worldwide had been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and more than 2.5 million had died. Uneasily, the coronavirus disease 2019 (COVID-19) pandemic is increasingly resembling the tragic 1918 influenza pandemic that killed more than 50 million people a century ago.	es_ES
dc.language.iso	eng	es_ES
dc.publisher	AIDS Reviews	es_ES
dc.relation.ispartofseries	;vol. 23, nº 1
dc.relation.uri	https://www.aidsreviews.com/resumen.php?id=1572	es_ES
dc.rights	openAccess	es_ES
dc.subject	antiviral agents	es_ES
dc.subject	COVID-19	es_ES
dc.subject	COVID-19 vaccines	es_ES
dc.subject	humans	es_ES
dc.subject	SARS-CoV-2	es_ES
dc.subject	Scopus(2)	es_ES
dc.subject	JCR	es_ES
dc.title	New sars-cov-2 variants challenge vaccines protection	es_ES
dc.type	other	es_ES
reunir.tag	~OPU	es_ES
dc.identifier.doi	https://doi.org/10.24875/AIDSREV.M21000040

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.